By registering, you will receive our email newsletters and advertising promotions. You may unsubscribe at any time.
LAS VEGAS, NV (PRWEB) JANUARY 24, 2012
Cenegenics® Medical Institute launched a unique Heart Disease & Stroke Prevention Program this month that sets a new benchmark for preventive health, announced the age management medicine global leader. Partnering with three cardio-diagnostic leaders—Panasonic Healthcare Group, Berkeley HeartLab and Cleveland HeartLab™—Cenegenics created the most advanced program, combining the best aspects of the nation’s top laboratories who screen for cardiovascular disease. No other practice does that.
Cardiovascular disease claims more lives ever year than all cancers, diabetes, Alzheimer’s or accidents, per the AHA’s 2011 Heart Disease/Stroke update. Cenegenics is targeting the disease head on with next generation medicine and an innovative program designed by four experts in the field: Dr. Robert D. Willix, Jr., a former cardiovascular surgeon and Cenegenics’ Chief Medical Officer; and three cardiologists, Dr. George Shapiro (Cenegenics New York City), Dr. Cesar Pellerano (Cenegenics Miami) and Dr. Ernst Schwarz (professor of Medicine, UCLA’s David Geffen School of Medicine).
“Up until now, Cenegenics has focused entirely on age management medicine and proactive health. Our new Heart Disease & Stroke Prevention Program with an advanced screening technology is our first endeavor to not only target an illness, but show how our Cenegenics program can reduce the development of disease,” Willix said.
Cenegenics’ Heart Disease & Stroke Prevention Program is available to everyone, patient or not, and is recommended for a wide age group.
“Can you prevent premature death, a heart attack or stroke? Yes, but you’ve got to know the warning signs. Cenegenics helps you do that with our unique Heart Disease & Stroke Prevention Program, which includes genetic screening, advanced lipid panels, laboratory markers for plaque formation and assessments for inflammatory markers—a cause of cardiovascular disease leading to tissue damage, organ destruction, shift in the cellular matrix as well as potential blood clots and heart attacks,” Willix said.
Learn more about Cenegenics’ Heart Disease & Stroke Prevention Program by calling 888.412.8769.
For more information about Cenegenics, please visit them online, where you can register for quick access to the online Cenegenics Healthy Aging Kit: informative Guide to Healthy Aging, Executive Summary and media excerpts.
Our world class physicians create a personalized plan to help you feel 10+ years younger. You'll be more energetic, lose weight, sleep better, have more libido, and think more clearly. Click below to schedule a free consultation with one of our physicians. It's quick + easy.
Physicians can learn more about age management medicine directly by calling Cenegenics: Or visit the Cenegenics physician site to learn more about Cenegenics’ highly regarded, CME-accredited Physician Training & Certification in Age Management Medicine program.
Cenegenics® Medical Institute has forged a paradigm shift in medicine, developing a proactive medical approach for optimized health hailed as “next generation medicine” and garnering worldwide media attention. Headquartered in Las Vegas, Cenegenics serves over 20,000 patients globally—2,000 are physicians and their families. Cenegenics has 19 centers with others opening in the near future: Las Vegas, Nevada; Charleston, South Carolina; Boca Raton, Florida; Dallas, Texas; Arlington, Texas; Atlanta, Georgia; Chicago, Illinois; Beverly Hills, California; Philadelphia, Pennsylvania; Washington, DC; New York City, NY; Tulsa, OK; Jacksonville, FL; Atlantic City, NJ; Houston,TX; Denver, CO; Scottsdale, AZ; Boston, MA. Cenegenics also offers CME-accredited physician training and certification opportunities in age management medicine via the nonprofit Cenegenics Education and Research Foundation (CERF).More from our newsroom
Please log in again. The login page will open in a new window. After logging in you can close it and return to this page.